Source:http://linkedlifedata.com/resource/pubmed/id/15223229
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-6-29
|
pubmed:abstractText |
Transforming growth factor-beta (TGF-beta) is a pro-sclerotic growth factor implicated in the pathogenesis of diabetic nephropathy. betaig-h3 is an extracellular matrix protein which is induced in many cells by TGF-beta. This study examined urinary betaig-h3 excretion in diabetic patients with elevated urinary albumin excretion and the clinical application of urinary betaig-h3 as a marker of diabetic nephropathy. Urinary and serum betaig-h3 levels were determined by enzyme-linked immunosorbent assay in 163 type 2 diabetic patients and 101 healthy control subjects of comparable age and weight. The ratio of urinary betaig-h3 and TGF-beta to creatinine was analyzed in patients with different degree of nephropathy. The betaig-h3 to creatinine ratio in urine was elevated in all groups of type 2 diabetics with normoalbuminuria (101.6 +/- 9.27), microalbuminuria (120.2 +/- 14.48), and overt proteinuria (146.3 +/- 16.34), when compared with control subjects (64.8 +/- 7.14) (P < 0.01). There was a positive correlation between urinary betaig-h3 and TGF-beta excretion rate and a positive correlation between urinary betaig-h3 and albumin excretion rate (AER). These data show that urinary levels of betaig-h3 are elevated in type 2 diabetic patients with nephropathy and may be used as a marker of diabetic nephropathy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Creatinine,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Matrix Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/betaIG-H3 protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0168-8227
|
pubmed:author |
pubmed-author:BaeJong-SupJS,
pubmed-author:ChungSung-ChangSC,
pubmed-author:HaSung-WooSW,
pubmed-author:JeongGui-HwaGH,
pubmed-author:KimBo-WanBW,
pubmed-author:KimHyun-JiHJ,
pubmed-author:KimIn-SanIS,
pubmed-author:KimJung-GukJG,
pubmed-author:KimYong-LimYL,
pubmed-author:ParkSun-HeeSH,
pubmed-author:YeeS CSC
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
167-73
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15223229-Albuminuria,
pubmed-meshheading:15223229-Biological Markers,
pubmed-meshheading:15223229-Blood Glucose,
pubmed-meshheading:15223229-Creatinine,
pubmed-meshheading:15223229-Diabetes Mellitus, Type 2,
pubmed-meshheading:15223229-Diabetic Nephropathies,
pubmed-meshheading:15223229-Extracellular Matrix Proteins,
pubmed-meshheading:15223229-Female,
pubmed-meshheading:15223229-Humans,
pubmed-meshheading:15223229-Insulin,
pubmed-meshheading:15223229-Male,
pubmed-meshheading:15223229-Middle Aged,
pubmed-meshheading:15223229-Reference Values,
pubmed-meshheading:15223229-Transforming Growth Factor beta
|
pubmed:year |
2004
|
pubmed:articleTitle |
Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
|
pubmed:affiliation |
Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|